Breast Cancer Testing Market, Global Outlook and Forecast 2022-2028

February 2022 | 66 pages | ID: B676D7CB3B7EEN
Market Monitor Global

Abstracts

Breast cancer is one of the most common malignant tumors in women, which poses a great threat to women's life and health.In recent years, as people pay more attention to women's health, the detection methods of their diseases have been greatly improved.Breast cancer tests include screening tests, diagnostic tests and monitoring tests.Screening tests, such as annual mammograms, are given regularly to people who appear healthy and who are not suspected of having breast cancer.The goal is to detect breast cancer early, before any symptoms appear, and cancer is often easier to treat.Diagnostic tests (such as biopsies) are for people suspected of having breast cancer (such as biopsies).These tests are used to determine whether breast cancer is present and, if so, whether it has reached the outside of the breast.Diagnostic tests are also used to gather more information about cancer to guide treatment decisions.Once breast cancer is diagnosed, many tests are used during and after treatment to monitor how well therapies are working. Monitoring tests also may be used to check for any signs of recurrence.

This report contains market size and forecasts of Breast Cancer Testing in Global, including the following market information:

Global Breast Cancer Testing Market Revenue, 2017-2022, 2023-2028, ($ millions)

Global top five companies in 2021 (%)

The global Breast Cancer Testing market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.

The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.

Screening Tests Segment to Reach $ Million by 2028, with a % CAGR in next six years.

The global key manufacturers of Breast Cancer Testing include Abbott, Alere, Becton Dickinson, BioMerieux, Roche, GE Healthcare, Hologic, Philips and PerkinElmer and etc. In 2021, the global top five players have a share approximately % in terms of revenue.

MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Breast Cancer Testing companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Breast Cancer Testing Market, by Type, 2017-2022, 2023-2028 ($ millions)

Global Breast Cancer Testing Market Segment Percentages, by Type, 2021 (%)

• Screening Tests
• Diagnostic Tests
• Monitoring Tests

Global Breast Cancer Testing Market, by Application, 2017-2022, 2023-2028 ($ millions)

Global Breast Cancer Testing Market Segment Percentages, by Application, 2021 (%)

• Non-invasive Breast Cancer
• Invasive Breast Cancer

Global Breast Cancer Testing Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)

Global Breast Cancer Testing Market Segment Percentages, By Region and Country, 2021 (%)

• North America
• US
• Canada
• Mexico
• Europe
• Germany
• France
• U.K.
• Italy
• Russia
• Nordic Countries
• Benelux
• Rest of Europe
• Asia
• China
• Japan
• South Korea
• Southeast Asia
• India
• Rest of Asia
• South America
• Brazil
• Argentina
• Rest of South America
• Middle East & Africa
• Turkey
• Israel
• Saudi Arabia
• UAE
• Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

Key companies Breast Cancer Testing revenues in global market, 2017-2022 (estimated), ($ millions)

Key companies Breast Cancer Testing revenues share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market, key players include:

• Abbott
• Alere
• Becton Dickinson
• BioMerieux
• Roche
• GE Healthcare
• Hologic
• Philips
• PerkinElmer
• Quest Diagnostics

Contents

1 INTRODUCTION TO RESEARCH & ANALYSIS REPORTS

1.1 Breast Cancer Testing Market Definition
1.2 Market Segments
  1.2.1 Market by Type
  1.2.2 Market by Application
1.3 Global Breast Cancer Testing Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
  1.5.1 Research Methodology
  1.5.2 Research Process
  1.5.3 Base Year
  1.5.4 Report Assumptions & Caveats

2 GLOBAL BREAST CANCER TESTING OVERALL MARKET SIZE

2.1 Global Breast Cancer Testing Market Size: 2021 VS 2028
2.2 Global Breast Cancer Testing Market Size, Prospects & Forecasts: 2017-2028
2.3 Key Market Trends, Opportunity, Drivers and Restraints
  2.3.1 Market Opportunities & Trends
  2.3.2 Market Drivers
  2.3.3 Market Restraints

3 COMPANY LANDSCAPE

3.1 Top Breast Cancer Testing Players in Global Market
3.2 Top Global Breast Cancer Testing Companies Ranked by Revenue
3.3 Global Breast Cancer Testing Revenue by Companies
3.4 Top 3 and Top 5 Breast Cancer Testing Companies in Global Market, by Revenue in 2021
3.5 Global Companies Breast Cancer Testing Product Type
3.6 Tier 1, Tier 2 and Tier 3 Breast Cancer Testing Players in Global Market
  3.6.1 List of Global Tier 1 Breast Cancer Testing Companies
  3.6.2 List of Global Tier 2 and Tier 3 Breast Cancer Testing Companies

4 MARKET SIGHTS BY PRODUCT

4.1 Overview
  4.1.1 by Type - Global Breast Cancer Testing Market Size Markets, 2021 & 2028
  4.1.2 Screening Tests
  4.1.3 Diagnostic Tests
  4.1.4 Monitoring Tests
4.2 By Type - Global Breast Cancer Testing Revenue & Forecasts
  4.2.1 By Type - Global Breast Cancer Testing Revenue, 2017-2022
  4.2.2 By Type - Global Breast Cancer Testing Revenue, 2023-2028
  4.2.3 By Type - Global Breast Cancer Testing Revenue Market Share, 2017-2028

5 SIGHTS BY APPLICATION

5.1 Overview
  5.1.1 By Application - Global Breast Cancer Testing Market Size, 2021 & 2028
  5.1.2 Non-invasive Breast Cancer
  5.1.3 Invasive Breast Cancer
5.2 By Application - Global Breast Cancer Testing Revenue & Forecasts
  5.2.1 By Application - Global Breast Cancer Testing Revenue, 2017-2022
  5.2.2 By Application - Global Breast Cancer Testing Revenue, 2023-2028
  5.2.3 By Application - Global Breast Cancer Testing Revenue Market Share, 2017-2028

6 SIGHTS BY REGION

6.1 By Region - Global Breast Cancer Testing Market Size, 2021 & 2028
6.2 By Region - Global Breast Cancer Testing Revenue & Forecasts
  6.2.1 By Region - Global Breast Cancer Testing Revenue, 2017-2022
  6.2.2 By Region - Global Breast Cancer Testing Revenue, 2023-2028
  6.2.3 By Region - Global Breast Cancer Testing Revenue Market Share, 2017-2028
6.3 North America
  6.3.1 By Country - North America Breast Cancer Testing Revenue, 2017-2028
  6.3.2 US Breast Cancer Testing Market Size, 2017-2028
  6.3.3 Canada Breast Cancer Testing Market Size, 2017-2028
  6.3.4 Mexico Breast Cancer Testing Market Size, 2017-2028
6.4 Europe
  6.4.1 By Country - Europe Breast Cancer Testing Revenue, 2017-2028
  6.4.2 Germany Breast Cancer Testing Market Size, 2017-2028
  6.4.3 France Breast Cancer Testing Market Size, 2017-2028
  6.4.4 U.K. Breast Cancer Testing Market Size, 2017-2028
  6.4.5 Italy Breast Cancer Testing Market Size, 2017-2028
  6.4.6 Russia Breast Cancer Testing Market Size, 2017-2028
  6.4.7 Nordic Countries Breast Cancer Testing Market Size, 2017-2028
  6.4.8 Benelux Breast Cancer Testing Market Size, 2017-2028
6.5 Asia
  6.5.1 By Region - Asia Breast Cancer Testing Revenue, 2017-2028
  6.5.2 China Breast Cancer Testing Market Size, 2017-2028
  6.5.3 Japan Breast Cancer Testing Market Size, 2017-2028
  6.5.4 South Korea Breast Cancer Testing Market Size, 2017-2028
  6.5.5 Southeast Asia Breast Cancer Testing Market Size, 2017-2028
  6.5.6 India Breast Cancer Testing Market Size, 2017-2028
6.6 South America
  6.6.1 By Country - South America Breast Cancer Testing Revenue, 2017-2028
  6.6.2 Brazil Breast Cancer Testing Market Size, 2017-2028
  6.6.3 Argentina Breast Cancer Testing Market Size, 2017-2028
6.7 Middle East & Africa
  6.7.1 By Country - Middle East & Africa Breast Cancer Testing Revenue, 2017-2028
  6.7.2 Turkey Breast Cancer Testing Market Size, 2017-2028
  6.7.3 Israel Breast Cancer Testing Market Size, 2017-2028
  6.7.4 Saudi Arabia Breast Cancer Testing Market Size, 2017-2028
  6.7.5 UAE Breast Cancer Testing Market Size, 2017-2028

7 PLAYERS PROFILES

7.1 Abbott
  7.1.1 Abbott Corporate Summary
  7.1.2 Abbott Business Overview
  7.1.3 Abbott Breast Cancer Testing Major Product Offerings
  7.1.4 Abbott Breast Cancer Testing Revenue in Global Market (2017-2022)
  7.1.5 Abbott Key News
7.2 Alere
  7.2.1 Alere Corporate Summary
  7.2.2 Alere Business Overview
  7.2.3 Alere Breast Cancer Testing Major Product Offerings
  7.2.4 Alere Breast Cancer Testing Revenue in Global Market (2017-2022)
  7.2.5 Alere Key News
7.3 Becton Dickinson
  7.3.1 Becton Dickinson Corporate Summary
  7.3.2 Becton Dickinson Business Overview
  7.3.3 Becton Dickinson Breast Cancer Testing Major Product Offerings
  7.3.4 Becton Dickinson Breast Cancer Testing Revenue in Global Market (2017-2022)
  7.3.5 Becton Dickinson Key News
7.4 BioMerieux
  7.4.1 BioMerieux Corporate Summary
  7.4.2 BioMerieux Business Overview
  7.4.3 BioMerieux Breast Cancer Testing Major Product Offerings
  7.4.4 BioMerieux Breast Cancer Testing Revenue in Global Market (2017-2022)
  7.4.5 BioMerieux Key News
7.5 Roche
  7.5.1 Roche Corporate Summary
  7.5.2 Roche Business Overview
  7.5.3 Roche Breast Cancer Testing Major Product Offerings
  7.5.4 Roche Breast Cancer Testing Revenue in Global Market (2017-2022)
  7.5.5 Roche Key News
7.6 GE Healthcare
  7.6.1 GE Healthcare Corporate Summary
  7.6.2 GE Healthcare Business Overview
  7.6.3 GE Healthcare Breast Cancer Testing Major Product Offerings
  7.6.4 GE Healthcare Breast Cancer Testing Revenue in Global Market (2017-2022)
  7.6.5 GE Healthcare Key News
7.7 Hologic
  7.7.1 Hologic Corporate Summary
  7.7.2 Hologic Business Overview
  7.7.3 Hologic Breast Cancer Testing Major Product Offerings
  7.7.4 Hologic Breast Cancer Testing Revenue in Global Market (2017-2022)
  7.7.5 Hologic Key News
7.8 Philips
  7.8.1 Philips Corporate Summary
  7.8.2 Philips Business Overview
  7.8.3 Philips Breast Cancer Testing Major Product Offerings
  7.8.4 Philips Breast Cancer Testing Revenue in Global Market (2017-2022)
  7.8.5 Philips Key News
7.9 PerkinElmer
  7.9.1 PerkinElmer Corporate Summary
  7.9.2 PerkinElmer Business Overview
  7.9.3 PerkinElmer Breast Cancer Testing Major Product Offerings
  7.9.4 PerkinElmer Breast Cancer Testing Revenue in Global Market (2017-2022)
  7.9.5 PerkinElmer Key News
7.10 Quest Diagnostics
  7.10.1 Quest Diagnostics Corporate Summary
  7.10.2 Quest Diagnostics Business Overview
  7.10.3 Quest Diagnostics Breast Cancer Testing Major Product Offerings
  7.10.4 Quest Diagnostics Breast Cancer Testing Revenue in Global Market (2017-2022)
  7.10.5 Quest Diagnostics Key News

8 CONCLUSION

9 APPENDIX

9.1 Note
9.2 Examples of Clients
9.3 Disclaimer

List Of Tables

LIST OF TABLES

Table 1. Breast Cancer Testing Market Opportunities & Trends in Global Market
Table 2. Breast Cancer Testing Market Drivers in Global Market
Table 3. Breast Cancer Testing Market Restraints in Global Market
Table 4. Key Players of Breast Cancer Testing in Global Market
Table 5. Top Breast Cancer Testing Players in Global Market, Ranking by Revenue (2021)
Table 6. Global Breast Cancer Testing Revenue by Companies, (US$, Mn), 2017-2022
Table 7. Global Breast Cancer Testing Revenue Share by Companies, 2017-2022
Table 8. Global Companies Breast Cancer Testing Product Type
Table 9. List of Global Tier 1 Breast Cancer Testing Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Breast Cancer Testing Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type – Global Breast Cancer Testing Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Breast Cancer Testing Revenue in Global (US$, Mn), 2017-2022
Table 13. By Type - Breast Cancer Testing Revenue in Global (US$, Mn), 2023-2028
Table 14. By Application – Global Breast Cancer Testing Revenue, (US$, Mn), 2021 & 2028
Table 15. By Application - Breast Cancer Testing Revenue in Global (US$, Mn), 2017-2022
Table 16. By Application - Breast Cancer Testing Revenue in Global (US$, Mn), 2023-2028
Table 17. By Region – Global Breast Cancer Testing Revenue, (US$, Mn), 2021 & 2028
Table 18. By Region - Global Breast Cancer Testing Revenue (US$, Mn), 2017-2022
Table 19. By Region - Global Breast Cancer Testing Revenue (US$, Mn), 2023-2028
Table 20. By Country - North America Breast Cancer Testing Revenue, (US$, Mn), 2017-2022
Table 21. By Country - North America Breast Cancer Testing Revenue, (US$, Mn), 2023-2028
Table 22. By Country - Europe Breast Cancer Testing Revenue, (US$, Mn), 2017-2022
Table 23. By Country - Europe Breast Cancer Testing Revenue, (US$, Mn), 2023-2028
Table 24. By Region - Asia Breast Cancer Testing Revenue, (US$, Mn), 2017-2022
Table 25. By Region - Asia Breast Cancer Testing Revenue, (US$, Mn), 2023-2028
Table 26. By Country - South America Breast Cancer Testing Revenue, (US$, Mn), 2017-2022
Table 27. By Country - South America Breast Cancer Testing Revenue, (US$, Mn), 2023-2028
Table 28. By Country - Middle East & Africa Breast Cancer Testing Revenue, (US$, Mn), 2017-2022
Table 29. By Country - Middle East & Africa Breast Cancer Testing Revenue, (US$, Mn), 2023-2028
Table 30. Abbott Corporate Summary
Table 31. Abbott Breast Cancer Testing Product Offerings
Table 32. Abbott Breast Cancer Testing Revenue (US$, Mn), (2017-2022)
Table 33. Alere Corporate Summary
Table 34. Alere Breast Cancer Testing Product Offerings
Table 35. Alere Breast Cancer Testing Revenue (US$, Mn), (2017-2022)
Table 36. Becton Dickinson Corporate Summary
Table 37. Becton Dickinson Breast Cancer Testing Product Offerings
Table 38. Becton Dickinson Breast Cancer Testing Revenue (US$, Mn), (2017-2022)
Table 39. BioMerieux Corporate Summary
Table 40. BioMerieux Breast Cancer Testing Product Offerings
Table 41. BioMerieux Breast Cancer Testing Revenue (US$, Mn), (2017-2022)
Table 42. Roche Corporate Summary
Table 43. Roche Breast Cancer Testing Product Offerings
Table 44. Roche Breast Cancer Testing Revenue (US$, Mn), (2017-2022)
Table 45. GE Healthcare Corporate Summary
Table 46. GE Healthcare Breast Cancer Testing Product Offerings
Table 47. GE Healthcare Breast Cancer Testing Revenue (US$, Mn), (2017-2022)
Table 48. Hologic Corporate Summary
Table 49. Hologic Breast Cancer Testing Product Offerings
Table 50. Hologic Breast Cancer Testing Revenue (US$, Mn), (2017-2022)
Table 51. Philips Corporate Summary
Table 52. Philips Breast Cancer Testing Product Offerings
Table 53. Philips Breast Cancer Testing Revenue (US$, Mn), (2017-2022)
Table 54. PerkinElmer Corporate Summary
Table 55. PerkinElmer Breast Cancer Testing Product Offerings
Table 56. PerkinElmer Breast Cancer Testing Revenue (US$, Mn), (2017-2022)
Table 57. Quest Diagnostics Corporate Summary
Table 58. Quest Diagnostics Breast Cancer Testing Product Offerings
Table 59. Quest Diagnostics Breast Cancer Testing Revenue (US$, Mn), (2017-2022)

List Of Figures

LIST OF FIGURES

Figure 1. Breast Cancer Testing Segment by Type in 2021
Figure 2. Breast Cancer Testing Segment by Application in 2021
Figure 3. Global Breast Cancer Testing Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Breast Cancer Testing Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Breast Cancer Testing Revenue, 2017-2028 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Breast Cancer Testing Revenue in 2021
Figure 8. By Type - Global Breast Cancer Testing Revenue Market Share, 2017-2028
Figure 9. By Application - Global Breast Cancer Testing Revenue Market Share, 2017-2028
Figure 10. By Region - Global Breast Cancer Testing Revenue Market Share, 2017-2028
Figure 11. By Country - North America Breast Cancer Testing Revenue Market Share, 2017-2028
Figure 12. US Breast Cancer Testing Revenue, (US$, Mn), 2017-2028
Figure 13. Canada Breast Cancer Testing Revenue, (US$, Mn), 2017-2028
Figure 14. Mexico Breast Cancer Testing Revenue, (US$, Mn), 2017-2028
Figure 15. By Country - Europe Breast Cancer Testing Revenue Market Share, 2017-2028
Figure 16. Germany Breast Cancer Testing Revenue, (US$, Mn), 2017-2028
Figure 17. France Breast Cancer Testing Revenue, (US$, Mn), 2017-2028
Figure 18. U.K. Breast Cancer Testing Revenue, (US$, Mn), 2017-2028
Figure 19. Italy Breast Cancer Testing Revenue, (US$, Mn), 2017-2028
Figure 20. Russia Breast Cancer Testing Revenue, (US$, Mn), 2017-2028
Figure 21. Nordic Countries Breast Cancer Testing Revenue, (US$, Mn), 2017-2028
Figure 22. Benelux Breast Cancer Testing Revenue, (US$, Mn), 2017-2028
Figure 23. By Region - Asia Breast Cancer Testing Revenue Market Share, 2017-2028
Figure 24. China Breast Cancer Testing Revenue, (US$, Mn), 2017-2028
Figure 25. Japan Breast Cancer Testing Revenue, (US$, Mn), 2017-2028
Figure 26. South Korea Breast Cancer Testing Revenue, (US$, Mn), 2017-2028
Figure 27. Southeast Asia Breast Cancer Testing Revenue, (US$, Mn), 2017-2028
Figure 28. India Breast Cancer Testing Revenue, (US$, Mn), 2017-2028
Figure 29. By Country - South America Breast Cancer Testing Revenue Market Share, 2017-2028
Figure 30. Brazil Breast Cancer Testing Revenue, (US$, Mn), 2017-2028
Figure 31. Argentina Breast Cancer Testing Revenue, (US$, Mn), 2017-2028
Figure 32. By Country - Middle East & Africa Breast Cancer Testing Revenue Market Share, 2017-2028
Figure 33. Turkey Breast Cancer Testing Revenue, (US$, Mn), 2017-2028
Figure 34. Israel Breast Cancer Testing Revenue, (US$, Mn), 2017-2028
Figure 35. Saudi Arabia Breast Cancer Testing Revenue, (US$, Mn), 2017-2028
Figure 36. UAE Breast Cancer Testing Revenue, (US$, Mn), 2017-2028
Figure 37. Abbott Breast Cancer Testing Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 38. Alere Breast Cancer Testing Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 39. Becton Dickinson Breast Cancer Testing Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 40. BioMerieux Breast Cancer Testing Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 41. Roche Breast Cancer Testing Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 42. GE Healthcare Breast Cancer Testing Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 43. Hologic Breast Cancer Testing Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 44. Philips Breast Cancer Testing Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 45. PerkinElmer Breast Cancer Testing Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 46. Quest Diagnostics Breast Cancer Testing Revenue Year Over Year Growth (US$, Mn) & (2017-2022)